Create, analyze, optimize your ETF portfolio. Start now →
Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF
PILL performance and flow charts
Performance
Flows
Historic performance and flows
Data as of April 24, 2026| 1M | 3M | YTD | 1Y | 3Y | 5Y | |
|---|---|---|---|---|---|---|
| Perf. | +28.31% | +0.41% | -0.58% | +139.21% | +36.39% | -41.15% |
| Flows | -$1M | -$6M | -$5M | -$9M | -$3M | +$1M |
Characteristics
The Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF is built to track the S&P Pharmaceuticals Select Industry Total Return Index - USD. This ETF provides synthetic exposure - by owning its shares you earn the return of the index indirectly through the use of derivatives or a swap. This share class generates a stream of income by distributing dividends.
| Management strategy | Passive |
| Strategy | Leveraged |
| Provider | Direxion |
| N° of holdings | |
| Replication method | Indirect |
| Asset class | Equity |
| Dividend policy | Distributing |
Trailing 12m distribution yield | Join for free |
| Inception date | November 15, 2017 |
| ESG | No |
More data and info about PILL on Trackinsight
PILL's exposure
This ETF provides synthetic exposure. It does not hold the securities of the index directly so we cannot display its exposure breakdown.
Trading data
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Volatility | +74.43% | +63.47% | +58.56% | +61.90% |
Max drawdown | -33.29% | -33.29% | -60.51% | -83.47% |
Max drawdown duration | 50d | 50d | 375d | 1779d |
Time to recover | 18d | 18d | 226d | N/A |
Replication quality
Data as of April 27, 2026Create an account to view replication metrics
1 year cumulative return difference | |
|---|---|
| Best | Join for free |
| Worst | Join for free |
| daily return difference | |
|---|---|
| Average | Join for free |
| Worst | Join for free |
What type of ETF is PILL?
PILL is a Passive ETF that provides exposure to Equity assets. It is managed by Direxion.
What index does PILL track?
PILL tracks the S&P Pharmaceuticals Select Industry Total Return Index - USD, aiming to replicate its performance through unfunded swap.
What does PILL invest in?
This ETF provides leveraged exposure (3x) to Equally Weighted US Pharmaceuticals Equities. It is part of the segment: Leveraged Equity.
What is the expense ratio of PILL?
The total expense ratio (TER) of PILL is 1.15%, representing the annual fee charged by the fund manager.
When was PILL launched?
PILL was launched on November 15, 2017, marking its entry into the ETF market.
Who is the issuer of PILL?
PILL is issued by Direxion.
What is the AUM of PILL?
As of April 24, 2026, PILL manages $12.79 M, reflecting the total assets held in the fund.
How has PILL performed recently?
As of April 24, 2026, PILL delivered a return of 28.31% over the past month (1M performance), 0.41% over the past three months (3M), and -0.58% year-to-date (YTD).
What are the recent fund flows for PILL?
As of April 24, 2026, PILL has seen net flows of -$1M in the past month (1M flow) and -$5M year-to-date (YTD).
Does PILL pay dividends?
As of April 24, 2026, PILL has a trailing 12-month distribution yield of 0.64%.
Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
Recent educational content
Asset TV
The ETF Show - Investors Can Fight Healthcare Inflation with Newly Launched ETFs
Adam Schenck, Principal and Managing Director of Fund Services at Milliman joined The ETF Show to discuss Milliman's first ETFs designed to hedge against rising healthcare inflation.
ETF Trends
ETF Industry KPIs April 20, 2026
The ETF Industry saw 14 New Launches, 1 Ticker Change and 16 closures last week.
Asset TV
The ETF Show - Investors Run to Cash Alternatives as Markets Remain Volatile
Jason England, Portfolio Manager and Fixed Income Strategist from Simplify joined The ETF Show to discuss investor allocations to fixed income as markets continue on their rollercoaster ride.
ETF Trends
ETF Industry KPIs March 30, 2026
The ETF Industry saw 33 New Launches, 1 Ticker Change and 9 closures last week.
Browse all educational columns
Calamos Investments Powers the Next Phase of the Autocallable Revolution
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
